Your session is about to expire
← Back to Search
Other
Fat Graft Myringoplasty + PRP for Ear Drum Perforation
N/A
Waitlist Available
Led By Manohar Bance, MD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Perforation present for at least 6 months (based on history or direct observation)
Be older than 18 years old
Must not have
Active ear infection at the time of the procedure
Cholesteatoma present
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if combining fat grafting and a special treatment can better heal small, chronic holes in the eardrum. The fat graft acts as a base for new tissue, and the special treatment helps speed up the healing process. This method is increasingly used for eardrum repair due to its effectiveness in enhancing closure rates and reducing complications.
Who is the study for?
This trial is for individuals with chronic ear drum perforations that are less than half the size of the tympanic membrane, visible from all edges, and present for at least 6 months. People with active ear infections, cholesteatoma, or those on immunosuppressive therapy or chemotherapy cannot participate.
What is being tested?
The study is testing if adding Platelet Rich Plasma (PRP) to the standard fat graft myringoplasty (FGM) improves healing in small ear drum perforations. Participants will be randomly assigned to receive either just FGM or FGM plus PRP and their healing rates compared after 3 months.
What are the potential side effects?
Potential side effects may include discomfort at the site where fat is grafted or blood is drawn for PRP, infection risks associated with any surgical procedure, and possible allergic reactions to materials used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a perforation for at least 6 months.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I currently have an ear infection.
Select...
I have a cholesteatoma.
Select...
I am currently on immunosuppressive therapy or chemotherapy.
Select...
I had a failed attempt at fixing a hole in my body.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Degree of perforation closure
Infection rate
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Fat graft with Platelet Rich PlasmaExperimental Treatment1 Intervention
Procedure as for as for Fat graft without PRP, but at Step 2 the Gelfoam will instead be soaked in PRP derived from the patient's own whole blood. The generation of PRP is descibed below: -
* 10-20 mL of autologous blood collected from an antecubital vein is placed in an adenosine citrate dextrose-acid (ACD-A) collection tube to prevent premature activation
* Blood immediately placed in the centrifuge at 1100g for 10 minutes (once)
* Supernatant removed and collected into syringe
* Injected onto surface of fat graft
* Rest added to piece of gelfoam
* Place gelfoam + PRP on the TM perforation
Group II: Fat graft without Platelet Rich PlasmaActive Control1 Intervention
Step 1. Under Local Anaesthetic (or General Anaesthetic if the patient is unable to tolerate this), a fat graft is taken from just behind the mastoid process, or more posteriorly just beneath the hairline if necessary. The graft is kept moist in 0.9% saline.The ear canal is injected with local anaesthetic and the edges of the perforation are freshened. Gelfoam is placed into the middle ear and the fat graft placed on top of this until it touches the underside of the TM and slightly bulges through. In an attempt to achieve standardisation of surgical technique between sites, surgeons will be provided with an operative video to watch beforehand.
Step 2. The fat graft will simply be covered with a piece of saline-soaked Gelfoam cut to completely cover the perforation and graft.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Fat Graft Myringoplasty (FGM) and Platelet Rich Plasma (PRP) are common treatments for ear drum perforation. FGM works by providing a physical scaffold that supports tissue regeneration and closure of the perforation.
PRP, derived from the patient's own blood, is rich in growth factors that accelerate the healing process by promoting cell proliferation and tissue repair. These mechanisms are crucial for patients as they enhance the natural healing process, potentially leading to faster recovery and improved outcomes in ear drum perforation treatment.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,562 Total Patients Enrolled
Manohar Bance, MDPrincipal InvestigatorCapital Health, Canada
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I currently have an ear infection.I have a cholesteatoma.I am currently on immunosuppressive therapy or chemotherapy.I had a failed attempt at fixing a hole in my body.I have had a perforation for at least 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Fat graft without Platelet Rich Plasma
- Group 2: Fat graft with Platelet Rich Plasma
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.